31 Jul 2019 10:04
31 July 2019 Polarean Imaging Plc
("Polarean" or the "Company")
Total Voting Rights
Polarean Imaging plc (AIM: POLX), the medical‑imaging technology company, with a proprietary drug‑device combination product for the magnetic resonance imaging (MRI) market, announces that the total number of shares in issue and total voting rights as at the date of this announcement is 114,438,600 ordinary shares of £0.00037 each.
The total issued share capital of the Company consists of 114,438,600 Ordinary Shares. This number may be used by Shareholders as the denominator for the calculation by which they will determine if they are required to notify their interest in, or change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.
Enquiries:
Polarean Imaging plc | www.polarean.com / www.polarean-ir.com | ||
Richard Hullihen, Chief Executive Officer | Via Walbrook PR | ||
Richard Morgan, Chairman |
| ||
|
| ||
SP Angel Corporate Finance LLP | Tel: +44 (0)20 3470 0470 | ||
David Hignell / Lindsay Mair / Jamie Spotswood (Corporate Finance) Vadim Alexandre / Rob Rees (Corporate Broking) |
| ||
|
| ||
Walbrook PR | Tel: +44 (0)20 7933 8780 or polarean@walbrookpr.com | ||
Paul McManus / Anna Dunphy
| Mob: +44 (0)7980 541 893 / +44 (0)7879 741 001
| ||
polarean (POLX)